The provider uses either a transabdominal or transvaginal ultrasound to measure the fetal nuchal translucency, or the clear, fluid–filled space at the back of the neck, of the first or a single developing fetus during the first trimester to diagnose any abnormality or defect in the chromosomes of the fetus during development.
For clinical responsibility, terminology, tips and additional info
start codify free trial.